Ankylosing spondylitis
J Braun, J Sieper - The Lancet, 2007 - thelancet.com
Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial
skeleton, causing characteristic inflammatory back pain, which can lead to structural and …
skeleton, causing characteristic inflammatory back pain, which can lead to structural and …
[HTML][HTML] Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect
several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex …
several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex …
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
J Braun, R van den Berg, X Baraliakos… - Annals of the …, 2011 - ard.bmj.com
This first update of the ASAS/EULAR recommendations on the management of ankylosing
spondylitis (AS) is based on the original paper, a systematic review of existing …
spondylitis (AS) is based on the original paper, a systematic review of existing …
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
Objective: To validate and refine two sets of candidate criteria for the classification/diagnosis
of axial spondyloarthritis (SpA). Methods: All Assessment of SpondyloArthritis international …
of axial spondyloarthritis (SpA). Methods: All Assessment of SpondyloArthritis international …
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
…, M Rudwaleit, X Baraliakos, J Brandt, J Braun… - Annals of the …, 2009 - ard.bmj.com
The field of spondyloarthritis (SpA) has experienced major progress in the last decade,
especially with regard to new treatments, earlier diagnosis, imaging technology and a better …
especially with regard to new treatments, earlier diagnosis, imaging technology and a better …
[HTML][HTML] SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the rapidly
unfolding coronavirus disease 2019 (COVID-19) pandemic 1, 2. Clinical manifestations of …
unfolding coronavirus disease 2019 (COVID-19) pandemic 1, 2. Clinical manifestations of …
Retinoic acid embryopathy
…, ND Agnish, PJ Benke, JT Braun… - … England Journal of …, 1985 - Mass Medical Soc
Retinoic acid, an analogue of vitamin A, is known to be teratogenic in laboratory animals
and has recently been implicated in a few clinical case reports. To study the human …
and has recently been implicated in a few clinical case reports. To study the human …
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
Background Treatment options for patients with ankylosing spondylitis are few. We aimed to
assess the effectiveness of infliximab, an antibody to tumour necrosis factor (TNF)-α, in …
assess the effectiveness of infliximab, an antibody to tumour necrosis factor (TNF)-α, in …
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
…, P Sampaio-Barros, D Wiek, J Braun - Annals of the …, 2017 - ard.bmj.com
To update and integrate the recommendations for ankylosing spondylitis and the recommendations
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…
[HTML][HTML] Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension
…, PJ Gheeraert, LH Missault, JJ Braun… - … England Journal of …, 2003 - Mass Medical Soc
Background It is uncertain whether ambulatory blood-pressure measurements recorded for
24 hours in patients with treated hypertension predict cardiovascular events independently of …
24 hours in patients with treated hypertension predict cardiovascular events independently of …